Form 8-K - Current report:
SEC Accession No. 0001213900-25-103799
Filing Date
2025-10-30
Accepted
2025-10-30 08:31:50
Documents
12
Period of Report
2025-10-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0262960-8k_abvcbio.htm   iXBRL 8-K 26070
  Complete submission text file 0001213900-25-103799.txt   189851

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20251028.xsd EX-101.SCH 3011
3 XBRL LABEL FILE abvc-20251028_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE abvc-20251028_pre.xml EX-101.PRE 22356
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0262960-8k_abvcbio_htm.xml XML 3570
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 251432384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)